ARMC10: A Potential Drug Target and Biomarker (G83787)

Target Name: ARMC10

NCBI ID: G83787

ARMC10

ARMC10: A Potential Drug Target and Biomarker

Armadillo repeat containing 10 (ARMC10) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a highly conserved gene that is found in many organisms, including humans. The ARMADILLO Repeat Containing 10 gene has four exons, and its corresponding RNA product has five exons. ARMADILLO Repeat Containing 10 is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of stem cell proliferation and differentiation.

Drug Target Potential

ARMC10 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. The ARMADILLO Repeat Containing 10 gene has been shown to play a role in the regulation of T cell development and differentiation. It has also been shown to be involved in the regulation of cancer cell proliferation.

One of the ARMADILLO Repeat Containing 10 genes has been shown to encode a protein that is involved in cell adhesion. This protein is known as ARMADILLO Repeat Containing 10 (ARC), which is a protein that is involved in cell-cell adhesion. ARC has been shown to play a role in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

Another ARMADILLO Repeat Containing 10 gene has been shown to encode a protein that is involved in cell migration. This protein is known as ARMADILLO Repeat Containing 10 (AMX), which is a protein that is involved in cell migration. AMX has been shown to play a role in the regulation of cell migration, which is important for the development and maintenance of tissues and organs.

In addition to its role in cell adhesion and migration, ARMADILLO Repeat Containing 10 has also been shown to play a role in the regulation of stem cell proliferation and differentiation. It has been shown to be involved in the regulation of the stem cell marker GFP, which is a widely used tool for the study of stem cells.

Biomarker Potential

ARMC10 has also been identified as a potential biomarker for various diseases, including cancer. It has been shown to be involved in the regulation of cancer cell proliferation, which is important for the development and maintenance of cancer. In addition, ARMADILLO Repeat Containing 10 has also been shown to play a role in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

ARMC10 has also been shown to be involved in the regulation of inflammation. It has been shown to be involved in the regulation of the production of pro-inflammatory cytokines, which are important for the regulation of inflammation.

Conclusion

ARMC10 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is involved in various cellular processes, including cell adhesion, migration, and invasion, and has been shown to play a role in the regulation of T cell development and differentiation, cancer cell proliferation, and stem cell proliferation and differentiation. In addition, ARMADILLO Repeat Containing 10 has also been shown to be involved in the regulation of cell migration, inflammation, and other cellular processes. Further research is needed to fully understand the role of ARMADILLO Repeat Containing 10 in these processes and to determine its potential as a drug target and biomarker.

Protein Name: Armadillo Repeat Containing 10

Functions: May play a role in cell survival and cell growth. May suppress the transcriptional activity of p53/TP53

The "ARMC10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARMC10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets